List Title | APhA DrugInfoLine

Focus on Diabetes Care

SORT BY: Most Recent Most Viewed

October 15, 2014

Intensive glucose control: Surprising benefits for heart disease

READ

PREVIEW
Data from a new post hoc analysis of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial suggest that intensive glycemic control may be associated with a 15%–20% reduction in...
August 5, 2014

Sulfonylurea + sulfa antibiotic: Increased hypoglycemia risk

READ

PREVIEW
Results of a recent study involving Medicare beneficiaries suggested that the risk of hypoglycemia is increased with the coadministration of trimethoprim/sulfamethoxazole antibiotics and...
July 29, 2014

Insulin-related hypoglycemia: Did we cause this problem?

READ

PREVIEW
Approximately 100,000 emergency department (ED) visits and 30,000 hospitalizations occur annually as a result of insulin-related hypoglycemia and errors, with the greatest risk occurring in...
July 1, 2014

Higher-potency statins increase diabetes risk

READ

PREVIEW
Observational data analyzing approximately 137,000 patients suggested that use of higher-potency statins may be associated with an increased risk of new-onset diabetes as compared with lower-...
June 24, 2014

Metformin-associated lactic acidosis: Truth or fiction?

READ

PREVIEW
Individuals taking metformin who present with lactic acidosis, renal failure, and/or a recent history of gastrointestinal symptoms may be experiencing metformin-associated toxicity, according to...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.